Katzenellenbogen J - Search Results

1

Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.

Lupien M, Jeyakumar M, Hébert E, Hilmi K, Cotnoir-White D, Loch C, Auger A, Dayan G, Pinard GA, Wurtz JM, Moras D, Katzenellenbogen J, Mader S. Lupien M, et al. Among authors: katzenellenbogen j. Mol Endocrinol. 2007 Apr;21(4):797-816. doi: 10.1210/me.2006-0074. Epub 2007 Feb 13. Mol Endocrinol. 2007. PMID: 17299137

2

Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.

Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA. Gee AC, et al. Among authors: katzenellenbogen bs, katzenellenbogen ja. Mol Endocrinol. 1999 Nov;13(11):1912-23. doi: 10.1210/mend.13.11.0373. Mol Endocrinol. 1999. PMID: 10551784

3

Antagonists selective for estrogen receptor alpha.

Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Sun J, et al. Among authors: katzenellenbogen bs, katzenellenbogen ja. Endocrinology. 2002 Mar;143(3):941-7. doi: 10.1210/endo.143.3.8704. Endocrinology. 2002. PMID: 11861516

4

Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.

Tamrazi A, Carlson KE, Daniels JR, Hurth KM, Katzenellenbogen JA. Tamrazi A, et al. Mol Endocrinol. 2002 Dec;16(12):2706-19. doi: 10.1210/me.2002-0250. Mol Endocrinol. 2002. PMID: 12456792

5

Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile.

Sun J, Baudry J, Katzenellenbogen JA, Katzenellenbogen BS. Sun J, et al. Among authors: katzenellenbogen bs, katzenellenbogen ja. Mol Endocrinol. 2003 Feb;17(2):247-58. doi: 10.1210/me.2002-0341. Mol Endocrinol. 2003. PMID: 12554752

6

Molecular sensors of estrogen receptor conformations and dynamics.

Tamrazi A, Carlson KE, Katzenellenbogen JA. Tamrazi A, et al. Mol Endocrinol. 2003 Dec;17(12):2593-602. doi: 10.1210/me.2003-0239. Epub 2003 Aug 28. Mol Endocrinol. 2003. PMID: 12947047

7

Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.

Tsai HW, Katzenellenbogen JA, Katzenellenbogen BS, Shupnik MA. Tsai HW, et al. Endocrinology. 2004 Jun;145(6):2730-8. doi: 10.1210/en.2003-1470. Epub 2004 Mar 19. Endocrinology. 2004. PMID: 15033909

8

Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.

Tamrazi A, Carlson KE, Rodriguez AL, Katzenellenbogen JA. Tamrazi A, et al. Mol Endocrinol. 2005 Jun;19(6):1516-28. doi: 10.1210/me.2004-0458. Epub 2005 Jan 20. Mol Endocrinol. 2005. PMID: 15661830

9

Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.

Dayan G, Lupien M, Auger A, Anghel SI, Rocha W, Croisetière S, Katzenellenbogen JA, Mader S. Dayan G, et al. Mol Pharmacol. 2006 Aug;70(2):579-88. doi: 10.1124/mol.105.021931. Epub 2006 May 5. Mol Pharmacol. 2006. PMID: 16679488

10

Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity.

Likhite VS, Stossi F, Kim K, Katzenellenbogen BS, Katzenellenbogen JA. Likhite VS, et al. Mol Endocrinol. 2006 Dec;20(12):3120-32. doi: 10.1210/me.2006-0068. Epub 2006 Aug 31. Mol Endocrinol. 2006. PMID: 16945990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters